| Literature DB >> 30139807 |
H Cody Meissner1, Karen Farizo2, Douglas Pratt2, Larry K Pickering3, Amanda C Cohn4.
Abstract
Adherence to recommendations for the use of licensed vaccines ensures maximum individual and societal benefits from the national immunization program. The US Food and Drug Administration (FDA) licenses a vaccine once it determines that data submitted by the manufacturer reveal that the vaccine is safe and effective for its intended use. For each US-licensed vaccine, the FDA-approved prescribing information contains detailed information for health care providers to ensure safe and effective use. Centers for Disease Control and Prevention recommendations for the use of a licensed vaccine often are based on additional considerations, such as disease epidemiology, public acceptance, vaccine supply, and cost. Our objective in this article is to explain the reasons for the differences between FDA-approved prescribing information and Centers for Disease Control and Prevention recommendations for vaccine use.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30139807 PMCID: PMC8988052 DOI: 10.1542/peds.2018-0780
Source DB: PubMed Journal: Pediatrics ISSN: 0031-4005 Impact factor: 7.124